{
 "generated": "2026-10-09",
 "method": "#21 v-safe (COVID-19) free-text, MedDRA-coded: registrant-level counts for AESIs.\n\nInput: data/vsafe/output/meddra_covid_meddra_{sd,sro,hcvo}.parquet \u2014 MedDRA coding of the three\nfree-text fields in the released v-safe COVID-19 survey data (SD = symptom description, SRO =\n\"other\" systemic reaction, HCVO = \"other\" reason for a health-care visit). The structured\ncheck-box answers and the total number of registrants are NOT in these files, so the only\nhonest denominator is the number of distinct registrants who typed text in that field.\nOutput: data/science/vsafe_aesi.json (per field: registrants with text, top PTs, AESI PTs,\nand the survey timepoints at which AESI PTs were first mentioned).\n",
 "fields": {
  "sd": {
   "field": "Symptom description (free text)",
   "registrants_with_text": 2191402,
   "rows": 7923602,
   "top_pts": {
    "Headache": 399633,
    "Fatigue": 381342,
    "Cough": 372296,
    "Oropharyngeal pain": 283684,
    "COVID-19": 254960,
    "Nasopharyngitis": 210024,
    "Pyrexia": 204166,
    "Pain": 190004,
    "Respiratory tract congestion": 189376,
    "Rhinorrhoea": 171600,
    "Pre-existing disease": 129144,
    "Arthralgia": 116684,
    "Diarrhoea": 113289,
    "Nausea": 107068,
    "Chills": 97935,
    "Nasal congestion": 89329,
    "SARS-CoV-2 test negative": 80769,
    "Dizziness": 79485,
    "Pain in extremity": 78640,
    "SARS-CoV-2 test positive": 76920
   },
   "aesi": {
    "Myocarditis / pericarditis": {
     "registrants": 1519,
     "per_10000_text_registrants": 6.931635546558779,
     "first_mention_timepoints": {
      "12-month-dose2": 308,
      "6-month-dose2": 276,
      "3-month-dose2": 157,
      "12-month-dose1": 79,
      "6-month-dose3": 73,
      "6-month-dose1": 63
     }
    },
    "Anaphylaxis": {
     "registrants": 725,
     "per_10000_text_registrants": 3.3083843128736765,
     "first_mention_timepoints": {
      "12-month-dose2": 93,
      "6-month-dose2": 83,
      "3-month-dose2": 65,
      "14-day-dose1": 51,
      "14-day-dose2": 33,
      "12-month-dose1": 30
     }
    },
    "Guillain-Barr\u00e9 syndrome": {
     "registrants": 259,
     "per_10000_text_registrants": 1.1818917752196996,
     "first_mention_timepoints": {
      "12-month-dose2": 44,
      "6-month-dose2": 27,
      "6-month-dose1": 22,
      "3-month-dose2": 22,
      "12-month-dose1": 21,
      "3-month-dose1": 15
     }
    },
    "Bell's palsy / facial paralysis": {
     "registrants": 2637,
     "per_10000_text_registrants": 12.033392321445358,
     "first_mention_timepoints": {
      "6-month-dose2": 375,
      "3-month-dose2": 298,
      "12-month-dose2": 288,
      "14-day-dose1": 267,
      "14-day-dose2": 156,
      "21-day-dose2": 104
     }
    },
    "Syncope": {
     "registrants": 4821,
     "per_10000_text_registrants": 21.999614858433095,
     "first_mention_timepoints": {
      "6-month-dose2": 574,
      "3-month-dose2": 451,
      "12-month-dose2": 433,
      "14-day-dose1": 357,
      "14-day-dose2": 299,
      "28-day-dose2": 227
     }
    },
    "Chest pain": {
     "registrants": 56204,
     "per_10000_text_registrants": 256.4750785113822,
     "first_mention_timepoints": {
      "14-day-dose1": 6134,
      "6-month-dose2": 5713,
      "3-month-dose2": 4956,
      "12-month-dose2": 4941,
      "14-day-dose2": 3913,
      "21-day-dose2": 3168
     }
    },
    "Tinnitus": {
     "registrants": 20248,
     "per_10000_text_registrants": 92.39746974767752,
     "first_mention_timepoints": {
      "3-month-dose2": 2256,
      "12-month-dose2": 2159,
      "6-month-dose2": 1804,
      "14-day-dose1": 1715,
      "14-day-dose2": 1549,
      "21-day-dose2": 1225
     }
    },
    "Herpes zoster": {
     "registrants": 17287,
     "per_10000_text_registrants": 78.88557188503069,
     "first_mention_timepoints": {
      "6-month-dose2": 2527,
      "3-month-dose2": 2358,
      "12-month-dose2": 1652,
      "14-day-dose1": 1195,
      "14-day-dose2": 996,
      "21-day-dose2": 770
     }
    },
    "Thrombosis / embolism": {
     "registrants": 8166,
     "per_10000_text_registrants": 37.263815584726125,
     "first_mention_timepoints": {
      "6-month-dose2": 1306,
      "12-month-dose2": 1170,
      "3-month-dose2": 934,
      "6-month-dose3": 349,
      "14-day-dose1": 338,
      "14-day-dose2": 309
     }
    },
    "Menstrual disorder": {
     "registrants": 37879,
     "per_10000_text_registrants": 172.8528129480579,
     "first_mention_timepoints": {
      "3-month-dose2": 6044,
      "6-month-dose2": 5039,
      "12-month-dose2": 3076,
      "14-day-dose2": 2665,
      "21-day-dose2": 2572,
      "14-day-dose1": 2302
     }
    }
   }
  },
  "sro": {
   "field": "Other systemic reaction (free text)",
   "registrants_with_text": 2180183,
   "rows": 5844757,
   "top_pts": {
    "No adverse event": 267553,
    "Dizziness": 216287,
    "Lymphadenopathy": 134903,
    "Oropharyngeal pain": 134276,
    "Injection site pain": 121473,
    "Fatigue": 120800,
    "Pain in extremity": 120498,
    "Unevaluable event": 118288,
    "Headache": 102687,
    "Pain": 98161,
    "Cough": 94953,
    "Rhinorrhoea": 76266,
    "Pre-existing disease": 76054,
    "Pyrexia": 74731,
    "Chills": 67124,
    "Arthralgia": 57306,
    "Feeling abnormal": 52356,
    "Axillary pain": 52195,
    "Adverse reaction": 51836,
    "Lymph node pain": 49534
   },
   "aesi": {
    "Myocarditis / pericarditis": {
     "registrants": 244,
     "per_10000_text_registrants": 1.1191721061947553,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 72,
      "1-6-daily-dose1": 43,
      "1-6-daily-dose3": 38,
      "7-day-dose2": 32,
      "7-day-dose1": 15,
      "7-day-dose3": 12
     }
    },
    "Anaphylaxis": {
     "registrants": 768,
     "per_10000_text_registrants": 3.5226400719572624,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 325,
      "0-day-dose1": 162,
      "1-6-daily-dose2": 117,
      "0-day-dose2": 80,
      "7-day-dose1": 41,
      "7-day-dose2": 13
     }
    },
    "Guillain-Barr\u00e9 syndrome": {
     "registrants": 53,
     "per_10000_text_registrants": 0.24309885913246732,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 23,
      "7-day-dose1": 9,
      "0-day-dose1": 8,
      "1-6-daily-dose2": 6,
      "1-6-daily-dose3": 2,
      "1-6-daily-dose4": 2
     }
    },
    "Bell's palsy / facial paralysis": {
     "registrants": 1133,
     "per_10000_text_registrants": 5.196811460322367,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 423,
      "1-6-daily-dose2": 286,
      "7-day-dose1": 142,
      "7-day-dose2": 87,
      "0-day-dose2": 58,
      "0-day-dose1": 55
     }
    },
    "Syncope": {
     "registrants": 7704,
     "per_10000_text_registrants": 35.33648322182129,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 3066,
      "1-6-daily-dose1": 2133,
      "0-day-dose1": 924,
      "1-6-daily-dose3": 462,
      "0-day-dose2": 341,
      "7-day-dose1": 192
     }
    },
    "Chest pain": {
     "registrants": 54124,
     "per_10000_text_registrants": 248.25438965444644,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 19892,
      "1-6-daily-dose2": 17784,
      "0-day-dose1": 3969,
      "1-6-daily-dose3": 3464,
      "7-day-dose1": 2781,
      "0-day-dose2": 2197
     }
    },
    "Tinnitus": {
     "registrants": 19811,
     "per_10000_text_registrants": 90.86851883534547,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 7267,
      "1-6-daily-dose1": 5860,
      "0-day-dose1": 1275,
      "1-6-daily-dose3": 1254,
      "0-day-dose2": 1193,
      "7-day-dose1": 892
     }
    },
    "Herpes zoster": {
     "registrants": 3262,
     "per_10000_text_registrants": 14.96204676396431,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 1014,
      "1-6-daily-dose1": 872,
      "7-day-dose1": 478,
      "7-day-dose2": 432,
      "1-6-daily-dose3": 125,
      "0-day-dose2": 124
     }
    },
    "Thrombosis / embolism": {
     "registrants": 985,
     "per_10000_text_registrants": 4.51796936312227,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 306,
      "1-6-daily-dose2": 273,
      "7-day-dose1": 141,
      "7-day-dose2": 116,
      "1-6-daily-dose3": 35,
      "0-day-dose2": 33
     }
    },
    "Menstrual disorder": {
     "registrants": 16439,
     "per_10000_text_registrants": 75.40192726940812,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 6233,
      "1-6-daily-dose1": 4943,
      "7-day-dose2": 1382,
      "7-day-dose1": 1201,
      "1-6-daily-dose3": 1179,
      "0-day-dose2": 454
     }
    }
   }
  },
  "hcvo": {
   "field": "Other reason for health-care visit (free text)",
   "registrants_with_text": 263253,
   "rows": 366420,
   "top_pts": {
    "Office visit": 155429,
    "Unevaluable event": 53697,
    "Medical counselling": 26591,
    "SARS-CoV-2 test": 9547,
    "Surgery": 7818,
    "Physiotherapy": 6483,
    "Emergency care": 5152,
    "Specialist consultation": 3241,
    "SARS-CoV-2 test negative": 2910,
    "Hospitalisation": 2903,
    "Medical observation": 2645,
    "Telemedicine": 2107,
    "Pre-existing disease": 1581,
    "Self-medication": 1258,
    "Adverse reaction": 1179,
    "Acupuncture": 1107,
    "COVID-19": 1082,
    "SARS-CoV-2 test positive": 1077,
    "No adverse event": 1061,
    "Pain": 846
   },
   "aesi": {
    "Myocarditis / pericarditis": {
     "registrants": 27,
     "per_10000_text_registrants": 1.0256293375574068,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 5,
      "7-day-dose2": 4,
      "12-month-dose2": 3,
      "3-month-dose2": 2,
      "12-month-dose3": 2,
      "35-day-dose1": 1
     }
    },
    "Anaphylaxis": {
     "registrants": 77,
     "per_10000_text_registrants": 2.9249429256266786,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 30,
      "1-6-daily-dose2": 15,
      "0-day-dose1": 8,
      "0-day-dose2": 4,
      "7-day-dose1": 4,
      "14-day-dose1": 2
     }
    },
    "Guillain-Barr\u00e9 syndrome": {
     "registrants": 9,
     "per_10000_text_registrants": 0.3418764458524689,
     "first_mention_timepoints": {
      "14-day-dose1": 2,
      "7-day-dose3": 2,
      "1-6-daily-dose1": 1,
      "3-month-dose1": 1,
      "28-day-single": 1,
      "6-month-dose1": 1
     }
    },
    "Bell's palsy / facial paralysis": {
     "registrants": 69,
     "per_10000_text_registrants": 2.6210527515355952,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 20,
      "1-6-daily-dose2": 12,
      "7-day-dose1": 7,
      "7-day-dose2": 6,
      "1-6-daily-dose3": 3,
      "0-day-dose2": 2
     }
    },
    "Syncope": {
     "registrants": 171,
     "per_10000_text_registrants": 6.49565247119691,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 39,
      "1-6-daily-dose2": 32,
      "0-day-dose1": 16,
      "12-month-dose2": 14,
      "6-month-dose2": 10,
      "3-month-dose2": 6
     }
    },
    "Chest pain": {
     "registrants": 482,
     "per_10000_text_registrants": 18.309382988987778,
     "first_mention_timepoints": {
      "1-6-daily-dose1": 102,
      "1-6-daily-dose2": 86,
      "12-month-dose2": 34,
      "6-month-dose2": 29,
      "3-month-dose2": 25,
      "1-6-daily-dose3": 25
     }
    },
    "Tinnitus": {
     "registrants": 161,
     "per_10000_text_registrants": 6.115789753583055,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 23,
      "1-6-daily-dose1": 18,
      "6-month-dose2": 12,
      "12-month-dose2": 12,
      "7-day-dose1": 9,
      "42-day-dose2": 7
     }
    },
    "Herpes zoster": {
     "registrants": 227,
     "per_10000_text_registrants": 8.622883689834493,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 40,
      "1-6-daily-dose1": 35,
      "7-day-dose1": 27,
      "7-day-dose2": 16,
      "6-month-dose2": 15,
      "12-month-dose2": 14
     }
    },
    "Thrombosis / embolism": {
     "registrants": 211,
     "per_10000_text_registrants": 8.015103341652328,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 24,
      "12-month-dose2": 18,
      "1-6-daily-dose1": 16,
      "3-month-dose2": 16,
      "7-day-dose2": 13,
      "6-month-dose2": 12
     }
    },
    "Menstrual disorder": {
     "registrants": 65,
     "per_10000_text_registrants": 2.4691076644900534,
     "first_mention_timepoints": {
      "1-6-daily-dose2": 8,
      "6-month-dose2": 8,
      "7-day-dose2": 6,
      "12-month-dose2": 6,
      "3-month-dose2": 5,
      "3-month-dose1": 4
     }
    }
   }
  }
 }
}